PDT Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-33,475
Closed -$762K 845
2024
Q3
$762K Buy
+33,475
New +$762K 0.07% 421
2022
Q3
Sell
-10,114
Closed -$117K 1109
2022
Q2
$117K Sell
10,114
-4,276
-30% -$49.5K 0.01% 876
2022
Q1
$266K Buy
14,390
+1,775
+14% +$32.8K 0.02% 744
2021
Q4
$249K Buy
+12,615
New +$249K 0.02% 722